The epidemiology of Alzheimer's disease: Laying the foundation for drug design, conduct, and analysis of clinical trials

Alzheimer's and Dementia

Volumn 8, Issue 3, 2012, Pages 237-242

  Yaffe, Kristine ^a   Tocco, Michael ^b   Petersen, Ronald C ^c   Sigler, Catherine ^d   Burns, Leah C ^e   Cornelius, Christel ^f   Khachaturian, Ara S ^g   Irizarry, Michael C ^h   Carrillo, Maria C ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d UNITED BIOSOURCE CORPORATION   (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f ASTRAZENECA R AND D   (Sweden)

^g Khachaturian and Associates   (United States)

^h GLAXOSMITHKLINE   (United States)

ⁱ ALZHEIMER'S ASSOCIATION   (United States)

Author keywords

Aging; Alzheimer's disease; Dementia; Epidemiology; Mild cognitive impairment

Indexed keywords

AGE; AGING; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; DRUG DESIGN; DRUG SAFETY; HIGH RISK POPULATION; HUMAN; METHODOLOGY; OBSERVATIONAL STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT;

ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS AS TOPIC; DRUG DESIGN; EPIDEMIOLOGIC STUDIES; HUMANS; INTERNATIONAL COOPERATION;

EID: 84860447272     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.12.005     Document Type: Conference Paper

References (44)

1. R.L. Ownby, E. Crocco, A. Acevedo, V. John, and D. Loewenstein Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis Arch Gen Psychiatry 63 2006 530 538
2. M.A. Rapp, M. Schnaider-Beeri, H.T. Grossman, M. Sano, D.P. Perl, and D.P. Purohit Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression Arch Gen Psychiatry 63 2006 161 167 (Pubitemid 43213877)
3. Y.I. Sheline, M.H. Gado, and H.C. Kraemer Untreated depression and hippocampal volume loss Am J Psychiatry 160 2003 1516 1518 (Pubitemid 41070930)
4. P.P. Zandi, J.C. Anthony, A.S. Khachaturian, S.V. Stone, D. Gustafson, and J.T. Tschanz Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study Arch Neurol 61 2004 82 88 (Pubitemid 38067418)
5. A.B. Mendelsohn, S.H. Belle, G.P. Stoehr, and M. Ganguli Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey Am J Epidemiol 148 1998 38 44 (Pubitemid 28317543)
6. R. Whitmer, C.P. Quesenberry, J. Zhou, and K. Yaffe Timing of hormone therapy and dementia: the critical window theory re-visited Ann Neurol 69 2011 163 169
7. B.K. Martin, C. Szekely, J. Brandt, S. Piantadosi, J.C. Breitner, and S. Craft Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib Arch Neurol 65 2008 896 905 (Pubitemid 352008472)
8. J.C. Breitner, L.D. Baker, T.J. Montine, C.L. Meinert, C.G. Lyketsos, and K.H. Ashe Extended results of the Alzheimer's disease anti-inflammatory prevention trial Alzheimers Dement 7 2011 402 411
9. C.A. Szekely, R.C. Green, J.C. Breitner, T. Ostbye, A.S. Beiser, and M.M. Corrada No advantage of Abeta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies Neurology 70 2008 2291 2298
10. S.T. DeKosky, J.D. Williamson, A.L. Fitzpatrick, R.A. Kronmal, D.G. Ives, and J.A. Saxton Ginkgo biloba for prevention of dementia: a randomized controlled trial JAMA 300 2008 2253 2262
11. S. Andrieu, P.J. Ousset, N. Coley, M. Ouzid, H. Mathiex-Fortunet, and B. Vellas GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints: part i. rationale, design and baseline data Curr Alzheimer Res 5 2008 406 415
12. N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, and B. Vellas Dementia prevention: methodological explanations for inconsistent results Epidemiol Rev 30 2008 35 66
13. D.A. Evans, D.A. Bennett, R.S. Wilson, J.L. Bienias, M.C. Morris, and P.A. Scherr Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status Arch Neurol 60 2003 185 189 (Pubitemid 36193961)
14. G.G. Fillenbaum, A. Heyman, M.S. Huber, M.A. Woodbury, J. Leiss, and K.E. Schmader The prevalence and 3-year incidence of dementia in older Black and White community residents J Clin Epidemiol 51 1998 587 595 (Pubitemid 28376968)
15. A.L. Fitzpatrick, L.H. Juller, D.G. Ives, O.L. Lopez, W. Jagust, and J.C. Breitner Incidence and prevalence of dementia in the Cardiovascular Health Study J Am Geriatr Soc 52 2004 195 204 (Pubitemid 38233480)
16. M.X. Tang, Y. Stern, K. Marder, K. Bell, B. Gurland, and R. Lantigua The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics JAMA 279 1998 751 755 (Pubitemid 28114999)
17. Alzheimer's Association Alzheimer's disease facts and figures 2010 Alzheimer's Association Chicago, IL
18. J.C. Morris, R.C. Mohs, H. Rogers, G. Fillenbaum, and A. Heyman Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease Psychopharmacol Bull 24 1988 641 652 (Pubitemid 19054370)
19. J.C. Morris, A. Heyman, R.C. Mohs, J.P. Hughes, G. van Belle, and G. Fillenbaum The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part I. Clinical and neuropsychological assessment of Alzheimer's disease Neurology 39 1989 1159 1165 (Pubitemid 19239715)
20. A. Heyman, G.G. Fillenbaum, and S.S. Mirra Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical, neuropsychological, and neuropathological components Aging (Milano) 2 1990 415 424
21. J.D. Goos, M.I. Kester, F. Barkhof, M. Klein, M.A. Blankenstein, and P Scheltens Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition Stroke 40 2009 3455 3460
22. D. Boche, E. Zotova, R.O. Weller, S. Love, J.W. Neal, and R.M. Pickering Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain Brain 131 Pt 12 2008 3299 3310
23. W.J. Henneman, J.D. Sluimer, C. Cordonnier, M.M. Baak, P. Scheltens, and F. Barkhof MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population Stroke 40 2009 492 498
24. J.D. Goos, W.J. Henneman, J.D. Sluimer, H. Vrenken, I.C. Sluimer, and F. Barkhof Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population Neurology 74 2010 1954 1960
25. R.A. Sperling, C.R. Jack Jr., S.E. Black, M.P. Frosch, S.M. Greenberg, and B.T. Hyman Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup Alzheimers Dement 7 2011 367 385
26. C. DeCarli, J Massaro, D Harvey, J Hald, M Tulberg, and R Au Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal Neurobiol Aging 26 2005 491 510 (Pubitemid 40093933)
27. T. Jeerakathil, PA Wolf, A Beiser, J Massaro, S Seshadri, and RB D'Agostino Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study Stroke 35 2004 1857 1861 (Pubitemid 38971865)
28. S. Debette, PA Wolf, A Beiser, R Au, JJ Himali, and A Pikula Association of parental dementia with cognitive and brain MRI measures in middle-aged adults Neurology 73 2009 2071 2078
29. E.H. Corder, and J. Caskey Early intervention in Alzheimer disease: the importance of APOE4 plus family history Neurology 73 2009 2054 2055
30. W. Huang, C. Qiu, E. von Strauss, B. Winblad, and L. Fratiglioni APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study Arch Neurol 61 2004 1930 1934 (Pubitemid 39612954)
31. M. Martinez, D Campion, A Brice, D Hannequin, B Dubois, and O. Didierjean Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease Arch Neurol 55 1998 810 816 (Pubitemid 28265697)
32. D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, and M.L. Hamshere Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nat Genet 41 2009 1088 1093
33. J.C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, and M. Hiltunen Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat Genet 41 2009 1094 1099
34. S. Seshadri, A.L. Fitzpatrick, M.A. Ikram, A.L. DeStefano, V. Gudnason, and M. Boada Genome-wide analysis of genetic loci associated with Alzheimer disease JAMA 303 2010 1832 1840
35. J.A. Schneider, Z. Arvanitakis, S.E. Leurgans, and D.A. Bennett The neuropathology of probable Alzheimer disease and mild cognitive impairment Ann Neurol 66 2009 200 208
36. D.A. Bennett, J.A. Schneider, R.S. Wilson, J.L. Bienias, and S.E. Arnold Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function Arch Neurol 61 2004 378 384 (Pubitemid 38327357)
37. R.C. Petersen, P.S. Aisen, L.A. Beckett, M.C. Donohue, A.C. Gamst, and D.J. Harvey Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 2010 201 209
38. C.C. Rowe, K.A. Ellis, M. Rimajova, P. Bourgeat, K.E. Pike, and G. Jones Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Neurobiol Aging 31 2010 1275 1283
39. A. Akomolafe, A. Beiser, J.B. Meigs, R. Au, R.C. Green, and L.A. Farrer Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study Arch Neurol 63 2006 1551 1555 (Pubitemid 44748797)
40. M.F. Elias, P.K. Elias, L.M. Sullivan, P.A. Wolf, and R.B. D'Agostino Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study Int J Obes Relat Metab Disord 27 2003 260 268 (Pubitemid 36255810)
41. W. Lieb, A.S. Beiser, RS Vasan, ZS Tan, R Au, and TB Harris Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging JAMA 302 2009 2565 2572
42. S. Seshadri, A. Beiser, J Selhub, PF Jacques, IH Rosenberg, and RB D'Aogstino Plasma homocysteine as a risk factor for dementia and Alzheimer's disease N Engl J Med 346 2002 476 483 (Pubitemid 34441738)
43. Z.S. Tan, AS Beiser, RS Vasan, R Roubenoff, CA Dinarello, and TB Harris Inflammatory markers and the risk of Alzheimer disease: the Framingham Study Neurology 68 2007 1902 1908 (Pubitemid 46848622)
44. D.F. Terry, MJ Pencina, RS Vasan, JM Murabito, PA Wolf, and MK Hayes Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants J Am Geriatr Soc 53 2005 1944 1950 (Pubitemid 41826072)